Emergent BioSolutions (EBS) Change in Taxes (2022 - 2026)

Emergent BioSolutions' Change in Taxes history runs 5 years deep, the most recent figure standing at $4.6 million for Q1 2026.

• On a quarterly basis, Change in Taxes rose 154.76% year-over-year to $4.6 million in Q1 2026; TTM through Mar 2026 was $11.3 million, a 1041.67% increase from a year earlier, with the FY2025 full-year figure at -$1.7 million, down 107.3% from the prior year.
• Change in Taxes climbed to $4.6 million in Q1 2026 per EBS's latest filing, from -$6.3 million in the prior quarter.
• Across five years, Change in Taxes topped out at $79.7 million in Q4 2022 and bottomed at -$40.9 million in Q2 2022.
• The 5-year median for Change in Taxes is -$0.0 (2024), against an average of $2.3 million.
• Across the five-year window, Change in Taxes slumped 284.78% in 2023 and surged 3.650722201600001e+17% in 2025, its largest moves.
• Year by year, Change in Taxes stood at $79.7 million in 2022, then plunged by 115.93% to -$12.7 million in 2023, then soared by 74.02% to -$3.3 million in 2024, then plunged by 90.91% to -$6.3 million in 2025, then soared by 173.02% to $4.6 million in 2026.
• Per Business Quant, the three latest EBS Change in Taxes figures stand at $4.6 million (Q1 2026), -$6.3 million (Q4 2025), and $6.2 million (Q3 2025).